Skip to main content

Cardax Inc. (CDXI)

OTCMKTS: CDXI · Delayed Price · USD
1.00 0.00 (0.00%)
Dec 2, 2021 4:00 PM EST - Market closed
Market Cap802,516
Revenue (ttm)500,710
Net Income (ttm)-5.43M
Shares Out802,516
EPS (ttm)-7.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume215
Open0.89
Previous Close1.00
Day's Range1.00 - 1.10
52-Week Range0.05 - 6.00
Beta1.02
Analystsn/a
Price Targetn/a
Earnings Daten/a

About CDXI

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a targ...

IndustryPharmaceuticals
Employees10
Stock ExchangeOTCMKTS
Ticker SymbolCDXI
Full Company Profile

News

There is no news available yet.